| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.67M | 37.08M | 36.99M | 39.11M | 51.98M | 55.51M |
| Gross Profit | 7.22M | 7.12M | 6.85M | 6.56M | 4.53M | 4.73M |
| EBITDA | 480.00K | 1.49M | 1.97M | 727.00K | 1.77M | -89.00K |
| Net Income | -3.13M | -2.04M | 390.00K | -804.00K | 439.00K | -1.16M |
Balance Sheet | ||||||
| Total Assets | 16.56M | 15.91M | 16.79M | 17.00M | 23.29M | 24.36M |
| Cash, Cash Equivalents and Short-Term Investments | 90.00K | 120.00K | 474.00K | 438.00K | 352.00K | 183.00K |
| Total Debt | 6.19M | 5.57M | 5.78M | 6.12M | 6.04M | 6.64M |
| Total Liabilities | 14.92M | 13.94M | 12.25M | 12.40M | 17.35M | 19.10M |
| Stockholders Equity | 1.64M | 1.97M | 4.53M | 4.59M | 5.95M | 5.26M |
Cash Flow | ||||||
| Free Cash Flow | -371.00K | 199.00K | 736.00K | 611.00K | 651.00K | 1.54M |
| Operating Cash Flow | 466.00K | 1.05M | 1.32M | 1.02M | 1.37M | 2.23M |
| Investing Cash Flow | -766.00K | -808.00K | -588.00K | -411.00K | -734.00K | -678.00K |
| Financing Cash Flow | 14.00K | -83.00K | -316.00K | -292.00K | -540.00K | -1.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.81B | 8.36 | 14.71% | 2.06% | 6.96% | 28.47% | |
71 Outperform | £475.09M | 11.83 | 12.64% | 7.01% | 8.58% | -15.81% | |
70 Outperform | £1.94B | 17.26 | 12.20% | 0.79% | 7.74% | 30.09% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | £2.86M | -2.48 | -94.96% | ― | 15.00% | -592.50% |